CVS
CVS Health Corp.
$104.15
+1.34
(+1.30%)
Mkt Cap
132.89B
Volume
4,443,810
52W Range
58.5-106.15
Sector
Healthcare
Beta
0.60
EPS (TTM)
2.31
P/E Ratio
45.09
Revenue (TTM)
407.90B
Rev Growth (5Y)
+8.4%
EPS Growth (5Y)
-23.9%
AlphaVal · Fair Value
What we estimate one share is worth
$76.68
Overvalued
moderate signal
35.8% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
C-
Stable Earnings Power
47.0 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.
Company Description
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 402.07B | 372.81B | 357.78B | 322.47B | 292.11B | 268.71B | 256.78B | 194.58B | 184.79B | 177.55B | 153.29B | 139.37B |
| Net Income | 1.77B | 4.61B | 8.34B | 4.31B | 8.00B | 7.18B | 6.63B | (594.00M) | 6.62B | 5.32B | 5.24B | 4.64B |
| EPS | 1.40 | 3.66 | 6.49 | 3.29 | 6.00 | 5.48 | 5.10 | -0.57 | 6.47 | 4.93 | 4.66 | 3.98 |
| Free Cash Flow | 7.81B | 6.33B | 10.39B | 13.45B | 15.74B | 13.43B | 10.39B | 6.83B | 6.09B | 7.92B | 6.17B | 6.00B |
| FCF / Share | 6.16 | 5.02 | 8.09 | 10.25 | 11.94 | 10.26 | 7.99 | 6.54 | 5.97 | 7.38 | 5.52 | 5.17 |
| Operating CF | 10.64B | 9.11B | 13.43B | 16.18B | 18.27B | 15.87B | 12.85B | 8.87B | 8.01B | 10.14B | 8.54B | 8.14B |
| Total Assets | 261.06B | 253.22B | 249.73B | 228.28B | 233.00B | 230.72B | 222.45B | 196.46B | 95.13B | 94.46B | 92.44B | 74.19B |
| Total Debt | 93.59B | 82.92B | 79.39B | 70.73B | 76.00B | 85.04B | 89.00B | 73.43B | 27.00B | 27.53B | 27.46B | 12.89B |
| Cash & Equiv | 8.51B | 8.59B | 8.20B | 12.95B | 9.41B | 7.85B | 5.68B | 4.06B | 1.70B | 3.37B | 2.46B | 2.48B |
| Book Value | 75.21B | 75.56B | 76.46B | 71.47B | 75.08B | 69.39B | 63.86B | 58.23B | 37.69B | 36.83B | 37.20B | 37.96B |
| Return on Equity | 0.02 | 0.06 | 0.11 | 0.06 | 0.11 | 0.10 | 0.10 | -0.01 | 0.18 | 0.14 | 0.14 | 0.12 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 100.43B | 105.69B | 102.87B | 98.92B | 94.59B | 97.71B | 95.43B | 91.23B | 88.44B | 93.81B | 89.76B | 88.92B |
| Net Income | 2.94B | 2.94B | (3.98B) | 1.02B | 1.78B | 1.64B | 87.00M | 1.77B | 1.11B | 2.05B | 2.26B | 1.90B |
| EPS | 2.31 | 2.32 | -3.13 | 0.81 | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.76 | 1.48 |
| Free Cash Flow | 3.40B | 2.61B | 98.00M | 1.29B | 3.81B | 1.09B | (1.42B) | 2.45B | 4.20B | (3.55B) | 2.17B | 5.32B |
| FCF / Share | 2.67 | 2.05 | 0.08 | 1.02 | 3.02 | 0.87 | -1.12 | 1.95 | 3.33 | -2.75 | 1.69 | 4.14 |
| Operating CF | 4.25B | 3.39B | 796.00M | 1.90B | 4.56B | 1.86B | (745.00M) | 3.09B | 4.90B | (2.64B) | 2.72B | 5.91B |
| Total Assets | 252.97B | 261.06B | 255.33B | 258.34B | 255.59B | 253.22B | 252.43B | 252.48B | 249.74B | 249.73B | 251.31B | 250.07B |
| Total Debt | 78.34B | 93.59B | 81.75B | 82.72B | 81.21B | 82.92B | 82.70B | 83.82B | 81.79B | 79.39B | 80.10B | 82.14B |
| Cash & Equiv | 9.54B | 8.51B | 9.15B | 11.79B | 10.08B | 8.59B | 6.88B | 12.51B | 9.80B | 8.20B | 13.04B | 13.81B |
| Book Value | 77.46B | 75.21B | 72.93B | 77.38B | 76.93B | 75.56B | 74.94B | 74.93B | 73.97B | 76.46B | 74.34B | 72.73B |
| Return on Equity | 0.04 | 0.04 | -0.05 | 0.01 | 0.02 | 0.02 | 0.00 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
CVS News
2 Recession-Resistant Dividend Stocks to Buy and Hold
CVS Health declares quarterly dividend
CVS Health declares quarterly dividend
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”
Here's Why CVS Health (CVS) is a Strong Momentum Stock
3 Absurdly Cheap Dividend Stocks to Buy With $1,000 in July
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Up 14.81% in a Year, COWZ Proves You Don’t Need Apple
Are You Looking for a Top Momentum Pick? Why CVS Health (CVS) is a Great Choice